• 1. Department of Extracorporeal Circulation, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P.R.China;
  • 2. Department of Extracorporeal Circulation, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518057, Guangdong, P.R.China;
JIANG Fuqing, Email: 18501050179@126.com; GUAN Yulong, Email: guanyulong@yahoo.com
Export PDF Favorites Scan Get Citation

Extracorporeal cardiopulmonary resuscitation (ECPR) is a salvage therapy for patients suffering cardiac arrest refractory to conventional resuscitation, and provides circulatory support in patients who fail to achieve a sustained return of spontaneous circulation. ECPR serves as a bridge therapy that maintains organ perfusion whilst the underlying etiology of the cardiac arrest is determined and treated. Increasing recognition of the survival benefit associated with ECPR has led to increased use of ECPR during the past decade. Commonly used indications for ECPR are: age<70 years, initial rhythm of ventricular fibrillation or ventricular tachycardia, witnessed arrest, bystander cardiopulmonary resuscitation within 5 min, failure to achieve sustained return of spontaneous circulation within 15 min of beginning cardiopulmonary resuscitation. This review provides an overview of ECPR utilization, recent outcomes, risk factors, and complications of ECPR. Identifying ECPR indications, rapid deployment of extracorporeal life support equipment, and high-quality ECPR management strategies are of paramount importance to improve survival.

Citation: LIANG Ying, JIANG Fuqing, GUAN Yulong. Research progress on extracorporeal cardiopulmonary resuscitation. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2021, 28(9): 1107-1113. doi: 10.7507/1007-4848.202101033 Copy

  • Previous Article

    Distal aortic remodeling after open repair of Stanford type A acute aortic dissection
  • Next Article

    Issues on left ventricular decompression during veno-arterial extracorporeal membrane oxygenation in cardiogenic shock patients